Leadership Team

David P. Hochman

Chairman of the Board of Directors and Chief Executive Officer

Mr. Hochman has over 20 years of venture capital and investment banking experience. Since 2007, Mr. Hochman has been Managing Partner of Orchestra Medical Ventures, LLC, an investment firm that employs a strategy to create, build and invest in medical technology companies intended to generate substantial clinical value.

Darren R. Sherman

President, Chief Operating Officer and Director

Mr. Sherman has over 24 years of management and entrepreneurial experience in the medical technology industry spanning interventional cardiology, cardiac electrophysiology, sudden cardiac death, stroke, surgery, GI, and neurovascular therapies.

Evan Ballantyne

Chief Financial Officer

Mr. Ballantyne is an experienced financial and strategic leader in the biotech, medical device and information services industries with a proven track record of building and strengthening a company’s financial position during his career of more than 25 years.

Dennis Donohoe, M.D.

Chief Medical Officer

Dr. Dennis Donohoe, M.D. currently serves as the Chief Medical Officer for the Vascular Interventions Business Unit.  For the past eight years, Dr. Donohoe has served as clinical and regulatory consultant for a variety of device companies.

Yuval Mika, Ph. D.

General Manager and Chief Technology Officer, Cardiac Neuromodulation

Dr. Yuval Mika, Ph.D. was one of the founders of BackBeat and the leader in the development of BackBeat Cardiac Neuromodulation Therapy from concept and design of the device through preclinical and clinical work demonstrating the effect of the therapy in lowering blood pressure. Dr. Mika has 25 years of experience in the medical device industry, bringing technologies from concept to commercialization.

Inessa Wheeler

Vice President, Strategy & Marketing

Ms. Wheeler is a proven healthcare strategic marketing executive with over 15 years of experience in marketing strategy and commercial program development.

Eileen Bailey

Vice President, Quality and Regulatory

Ms. Eileen Bailey will be the Vice President of Quality and Regulatory Affairs for OBIO. Throughout her career, she has had the opportunity to be involved in all aspects of medical device and combination device product development through commercialization.

Semih Oktay, Ph.D.

Senior Regulatory Consultant

Dr. Semih Oktay, Ph.D. is the President and Founder of CardioMed Device Consultants. Prior to founding CardioMed, he was Vice President of Regulatory Affairs and Engineering at MicroMed Laboratories, Inc. (Petaluma, CA).

Steven Evans, M.D.

Chief Medical Officer, Cardiac Neuromodulation

Dr. Steven Evans, M.D. obtained his medical degree from New York University School of Medicine and completed his fellowship in Cardiovascular Disease and Electrophysiology at Cedars-Sinai Hospital.

Ziv Belsky

Vice President, Research & Development, Cardiac Neuromodulation

Mr. Belsky joins Orchestra BioMed having most recently served as Chief Technology Officer for NewPace Ltd., a cardiac rhythm management company based in Israel.

Norbert Rosenthal

Director, Clinical & Technical Operations, Cardiac Neuromodulation

Since 2013, Mr. Norbert Rosenthal has served as the Clinical Director and Technical Manager of BackBeat Medical, Inc., supporting BackBeat's clinical trials.

Jürgen Bernhard, Ph.D.

Director, Clinical Operations, Cardiac Neuromodulation

Dr. Jürgen Bernhard has over 23 years of medical device experience in the areas of clinical research, marketing and sales leadership.  Dr. Bernhard started his career in clinical research with Biotronik.

Daniel Burkhoff, M.D., PhD.

Director, Scientific & Medical, Cardiac Neuromodulation

After earning a Bachelors of Sciences degree from Cornell University in Applied and Engineering Physics, Dr. Daniel Burkhoff, M.D., Ph.D. obtained Doctorate of Philosophy and medical degrees from The Johns Hopkins School of Medicine and completed a fellowship in Cardiology at The Johns Hopkins Hospital.

Hikmat Hojeibane

Vice President, Research & Development, Cardiovascular Interventions

Mr. Hikmat Hojeibane is an accomplished R&D expert in the medtech industry with in depth knowledge and experience in product development, innovation and regulatory approvals.

William Baumbach, Ph.D.

Vice President, Scientific Affairs, Cardiovascular Interventions

Dr. Baumbach, Ph.D. has over 30 years of experience in pharmaceutical, biotechnology, and medical device R&D. Before co-founding Caliber Therapeutics in 2008, he was the Vice President of Research & Development at X-Cell Medical, a Drug-Eluting Stent startup that was based on a novel therapeutic agent, beta estradiol, that offered an enhanced safety profile.

Ron Dadino

Vice President, Pharmaceutical Development & Operations, Cardiovascular Interventions

Mr. Dadino joins Orchestra BioMed with more than 30 years of pharmaceutical experience and having commercialized over 20 pharmaceutical and combination products.

Greg Kopia, Ph.D., CMPP

Director, Pre-Clinical Development, Cardiovascular Interventions

Dr. Kopia joins the Orchestra BioMed team with more than 20 years’ experience in the preclinical evaluation of local therapies for cardiovascular disease encompassing both drugs and devices.

Have any questions?
Contact us at 917.254.4900 or info@orchestrabiomed.com